SK287175B6 - Kryštalické modifikácie sodnej soli 5-chlór-2-metoxy-N-[2-(4- metoxy-3-metylaminotiokarbonylaminosulfonylfenyl)etyl]benzamidu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom - Google Patents

Kryštalické modifikácie sodnej soli 5-chlór-2-metoxy-N-[2-(4- metoxy-3-metylaminotiokarbonylaminosulfonylfenyl)etyl]benzamidu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom Download PDF

Info

Publication number
SK287175B6
SK287175B6 SK1458-2001A SK14582001A SK287175B6 SK 287175 B6 SK287175 B6 SK 287175B6 SK 14582001 A SK14582001 A SK 14582001A SK 287175 B6 SK287175 B6 SK 287175B6
Authority
SK
Slovakia
Prior art keywords
methoxy
benzamide
sodium salt
chloro
ethyl
Prior art date
Application number
SK1458-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK14582001A3 (sk
Inventor
Heinrich Christian Englert
Uwe Gerlach
Tobias Metzenthin
Harald Schneider
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of SK14582001A3 publication Critical patent/SK14582001A3/sk
Publication of SK287175B6 publication Critical patent/SK287175B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1458-2001A 1999-04-16 2000-04-04 Kryštalické modifikácie sodnej soli 5-chlór-2-metoxy-N-[2-(4- metoxy-3-metylaminotiokarbonylaminosulfonylfenyl)etyl]benzamidu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom SK287175B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (2)

Publication Number Publication Date
SK14582001A3 SK14582001A3 (sk) 2002-01-07
SK287175B6 true SK287175B6 (sk) 2010-02-08

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1458-2001A SK287175B6 (sk) 1999-04-16 2000-04-04 Kryštalické modifikácie sodnej soli 5-chlór-2-metoxy-N-[2-(4- metoxy-3-metylaminotiokarbonylaminosulfonylfenyl)etyl]benzamidu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom

Country Status (33)

Country Link
US (1) US6723751B1 (de)
EP (2) EP1173418B1 (de)
JP (1) JP4662640B2 (de)
KR (1) KR100700302B1 (de)
CN (1) CN1168712C (de)
AR (1) AR023479A1 (de)
AT (2) ATE311364T1 (de)
AU (1) AU773246B2 (de)
BR (1) BR0010658A (de)
CA (1) CA2370388C (de)
CZ (1) CZ302459B6 (de)
DE (3) DE19917233A1 (de)
DK (1) DK1173418T3 (de)
EE (1) EE04612B1 (de)
ES (1) ES2251996T3 (de)
HK (1) HK1046270B (de)
HR (1) HRP20010744B1 (de)
HU (1) HU229082B1 (de)
IL (2) IL145921A0 (de)
ME (1) MEP55708A (de)
MX (1) MXPA01010275A (de)
MY (1) MY122588A (de)
NO (1) NO327798B1 (de)
NZ (1) NZ514788A (de)
PL (1) PL203809B1 (de)
RS (1) RS50916B (de)
RU (1) RU2235089C2 (de)
SI (1) SI1173418T1 (de)
SK (1) SK287175B6 (de)
TR (2) TR200501142T2 (de)
TW (1) TWI276622B (de)
WO (1) WO2000063167A1 (de)
ZA (1) ZA200108400B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5546715B2 (ja) * 2003-03-17 2014-07-09 日本たばこ産業株式会社 Ｃｅｔｐ阻害剤の医薬組成物
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0612724T3 (da) 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL141414A0 (en) * 1998-09-10 2002-03-10 Aventis Pharma Gmbh Use of benzenesulfonyl (thio) ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl (thio) ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
ZA200108400B (en) 2003-04-30
SI1173418T1 (sl) 2006-02-28
NO20015014D0 (no) 2001-10-15
CZ302459B6 (cs) 2011-06-01
NZ514788A (en) 2003-03-28
DE19917233A1 (de) 2000-10-19
HUP0200791A2 (hu) 2002-07-29
ATE311364T1 (de) 2005-12-15
TWI276622B (en) 2007-03-21
IL145921A0 (en) 2002-07-25
HUP0200791A3 (en) 2005-04-28
EP1173418A1 (de) 2002-01-23
CN1168712C (zh) 2004-09-29
JP2002542230A (ja) 2002-12-10
HU229082B1 (hu) 2013-07-29
ES2251996T3 (es) 2006-05-16
EE04612B1 (et) 2006-04-17
ATE414059T1 (de) 2008-11-15
US6723751B1 (en) 2004-04-20
DE60040811D1 (de) 2008-12-24
JP4662640B2 (ja) 2011-03-30
MY122588A (en) 2006-04-29
NO327798B1 (no) 2009-09-28
AU4542800A (en) 2000-11-02
KR100700302B1 (ko) 2007-03-29
MXPA01010275A (es) 2003-07-21
AU773246B2 (en) 2004-05-20
DK1173418T3 (da) 2006-04-10
YU72001A (sh) 2004-07-15
WO2000063167A1 (en) 2000-10-26
AR023479A1 (es) 2002-09-04
CA2370388C (en) 2009-10-13
DE60024431T2 (de) 2006-07-27
TR200501142T2 (tr) 2005-08-22
HRP20010744A2 (en) 2003-04-30
DE60024431D1 (en) 2006-01-05
CN1354744A (zh) 2002-06-19
HK1046270A1 (en) 2003-01-03
CZ20013672A3 (cs) 2002-01-16
MEP55708A (en) 2011-05-10
HK1046270B (zh) 2005-03-11
PL351245A1 (en) 2003-04-07
TR200102993T2 (tr) 2002-03-21
IL145921A (en) 2006-07-05
PL203809B1 (pl) 2009-11-30
NO20015014L (no) 2001-10-15
BR0010658A (pt) 2002-02-19
RS50916B (sr) 2010-08-31
EP1173418B1 (de) 2005-11-30
EE200100532A (et) 2002-12-16
EP1637519A1 (de) 2006-03-22
CA2370388A1 (en) 2000-10-26
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
HRP20010744B1 (en) 2010-08-31
EP1637519B1 (de) 2008-11-12
SK14582001A3 (sk) 2002-01-07

Similar Documents

Publication Publication Date Title
KR100275603B1 (ko) 아미노-치환된 벤조일구아니딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
NO179946B (no) Benzoylguanidiner og deres anvendelse som medikamenter
EP0723956B1 (de) Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
SK287175B6 (sk) Kryštalické modifikácie sodnej soli 5-chlór-2-metoxy-N-[2-(4- metoxy-3-metylaminotiokarbonylaminosulfonylfenyl)etyl]benzamidu, spôsob ich prípravy a farmaceutický prípravok s ich obsahom
CA2138930C (en) Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
CA2169696C (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
RU2165412C2 (ru) Бензоилгуанидины, способ их получения, способ ингибирования, фармацевтический состав и способ его получения
RU2379287C1 (ru) Замещенные сульфоны и сульфоксиды, обладающие антиаритмической активностью, лекарственные средства и фармацевтические композиции на их основе
HU221851B1 (hu) Fluor-alkil-csoporttal szubsztituált benzoil-guanidin-származékok, eljárás előállításukra, gyógyszerként történő alkalmazásuk, és ezeket tartalmazó gyógyszerkészítmények
US5631275A (en) Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
SK281876B6 (sk) Substituované benzénsulfonylmočoviny a benzénsulfonyltiomočoviny, spôsob ich výroby, ich použitie na výrobu farmaceutických prostriedkov a liečivá, ktoré ich obsahujú
SK287237B6 (sk) Deriváty cinamoylaminoalkylom substituovaných benzénsulfónamidov, spôsob ich prípravy a farmaceutický prostriedok

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150404